Watkin, Levi B
,
Jessen, Birthe
Wiszniewski, Wojciech
Vece, Timothy J
Jan, Max
Sha, Youbao
Thamsen, Maike
Santos-Cortez, Regie L P
Lee, Kwanghyuk
Gambin, Tomasz
Forbes, Lisa R
Law, Christopher S
Stray-Pedersen, Asbjørg
Cheng, Mickie H
Mace, Emily M
Anderson, Mark S
Liu, Dongfang
Tang, Ling Fung
Nicholas, Sarah K
Nahmod, Karen
Makedonas, George
Canter, Debra L
Kwok, Pui-Yan
Hicks, John
Jones, Kirk D
Penney, Samantha
Jhangiani, Shalini N
Rosenblum, Michael D
Dell, Sharon D
Waterfield, Michael R
Papa, Feroz R
Muzny, Donna M
Zaitlen, Noah
Leal, Suzanne M
Gonzaga-Jauregui, Claudia
Boerwinkle, Eric
Eissa, N Tony
Gibbs, Richard A
Lupski, James R
Orange, Jordan S
Shum, Anthony K
Article History
Received: 16 October 2014
Accepted: 19 March 2015
First Online: 20 April 2015
Competing interests
: J.R.L. has stock ownership in 23 and Me, is a paid consultant for Regeneron Pharmaceuticals, has stock options in Lasergen, Inc., and is a co-inventor on multiple US and European patents related to molecular diagnostics for inherited neuropathies, eye diseases and bacterial genomic fingerprinting. The Department of Molecular and Human Genetics at Baylor College of Medicine derives revenue from the chromosomal microarray analysis (CMA) and clinical exome sequencing offered in the Baylor Miraca Genetics Laboratory (BMGL). R.A.G. is an advisor to GE Healthcare/Clarient, Inc. and the Allen Institute for Brain Science and is interim CSO of the BMGL. The other authors have no disclosures relevant to the manuscript.